26 Nov, 2019

Associate Professor Danny Hatters

Bio21 Molecular Science and Biotechnology Institute

Impact of protein aggregation and protein quality control in Huntington’s disease


Danny Hatters is an NHMRC Senior Research Fellow (2019-2023) and runs a research laboratory to study how proteins misfold and interfere with cellular functions, with a particular focus on mechanisms related to neurodegenerative disease. The research combines building new tools, biosensors and methods using various aspects of protein biochemistry and cell biology. He completed his PhD at the University of Melbourne in 2002 studying the biophysics of amyloid formation. He then completed his post doc at the Gladstone Institutes/University of California, San Francisco under the mentorship of Dr Karl Weisgraber from 2002-2007 studying the structure and function of apolipoprotein E4 protein, which is an important modifier of Alzheimer’s disease risk. In 2007, he returned to Melbourne to take up a CR Roper Fellowship position in the Department of Biochemistry and Molecular Biology to establish his own (current) research program. In 2012 he was awarded an ARC Future Fellowship and appointed faculty member of the Dept of Biochemistry and Molecular Biology. He was deputy head of department from 2017-2019.

External Speaker – A Prof Danny Hatters (PDF)